Hydrochloride salt powder serving as a calcimimetic agent in API synthesis for hyperparathyroidism treatments. Procured by pharmaceutical manufacturers and biotech firms for tablet and capsule production in regulated GMP environments, distributed through B2B supply chains to hospitals and pharmacies.